Archive (english)

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

NEW ON THE MARKET

Donanemab (KISUNLA) in early Alzheimer’s disease

THERAPY FROM A CRITICAL VIEWPOINT

Acute cystitis: a comparison of fosfomycin, nitrofurantoin and pivmecillinam

Left atrial appendage closure – an option in atrial fibrillation?

a-t READERS QUESTIONS AND COMMENTS

On the duration of bisphosphonate therapy for osteoporosis

Statins: new meta-analysis on adverse effects

IN BRIEF

Cancer drug pembrolizumab (KEYTRUDA) – MSD’s cash cow

What is a “fair” price for a medicine?
free

Migraine drug lasmiditan (RAYVOW) withdrawn from the market worldwide

Lack of efficacy – tecovirimat loses its indication for Mpox

SIDE EFFECTS

Reminder: rebound effect caused by nasal drops and sprays

e a-t ON THE INTERNET

Donanemab (KISUNLA) in early Alzheimer’s disease (long version)

Left atrial appendage closure – an option in atrial fibrillation? (long version)

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles